Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Biopharmaceutical Fermentation Systems Market Forecast: What Value Will The Market Reach By 2030?
The biopharmaceutical fermentation systems market has experienced significant expansion in recent years. This market is projected to expand from $26.6 billion in 2025 to reach $28.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. Historically, this growth was driven by factors such as the early adoption of bioreactors, an increasing need for monoclonal antibodies, the expansion of biopharmaceutical research and development, the growth of contract manufacturing organization (CMO) and contract research organization (CRO) services, and innovations in fermentation equipment technology.
The biopharmaceutical fermentation systems market is poised for significant expansion over the next few years. It is projected to achieve a valuation of $41.42 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period stems from factors such as increasing biologics production, the rising demand for personalized medicine, the integration of automation into fermentation processes, market expansion in emerging economies, and favorable regulatory support for biopharmaceutical manufacturing. Prominent trends expected in this period encompass advanced bioreactor design and optimization, the adoption of single-use and disposable systems, the implementation of high-throughput fermentation techniques, sophisticated real-time process monitoring and analytics, and enhanced integration of upstream and downstream processes.
Get A Free Sample Report With In-Depth Market Insights:
Biopharmaceutical Fermentation Systems Market Growth Factors: What’s Supporting Expansion?
The expansion of the biologics pipeline is anticipated to drive the progress of the biopharmaceutical fermentation systems market in the future. Biologics are defined as medical items originating from living entities or their constituents, encompassing vaccines, blood fractions, gene-based treatments, tissues, and genetically engineered therapeutic proteins. This pipeline for biologics is expanding because of breakthroughs in biotechnology, improved comprehension of disease mechanisms, and an increasing need for specific and customized treatments. The biopharmaceutical fermentation systems market facilitates the development of biologics by allowing the large-scale culture of modified cells or microbes to generate intricate therapeutic proteins, antibodies, and vaccines for commercial use. As an illustration, in 2023, data from the National Library of Medicine, a US-based medical library, indicated that the U.S. Food and Drug Administration (FDA) cleared 55 novel drugs, comprising 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This represented a notable rise when contrasted with the 37 approvals recorded in 2022. Consequently, the expanding biologics pipeline is fueling the progression of the biopharmaceutical fermentation systems market.
Biopharmaceutical Fermentation Systems Market Segment Outlook: Which Categories Are Growing Fastest?
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
Subsegments:
1) By Upstream Products: Fermenters Or Bioreactors, Culture Media, Inoculum Preparation Systems, Gas And Liquid Flow Control Systems, Process Monitoring And Control Systems, Sterilization Systems
2) By Downstream Products: Filtration Systems, Centrifuges, Chromatography Systems, Ultrafiltration And Microfiltration Systems, Concentration And Purification Systems, Packaging And Storage Systems
Biopharmaceutical Fermentation Systems Market Industry Trends: What’s Reshaping Demand?
Major companies within the biopharmaceutical fermentation systems market are prioritizing the development of innovative solutions, such as intensified fixed-bed bioreactors, to enhance productivity and optimize large-scale biologics manufacturing processes. Intensified fixed-bed bioreactors are advanced fermentation systems that leverage densely packed, immobilized cells to achieve higher product yields and more efficient bioprocessing. For example, in October 2024, Univercells Technologies, a Belgium-based bioprocessing company, unveiled the scale-X nexo bioreactor, a miniaturized fixed-bed system. This system features a compact 0.5 m² growth surface that operates in merely ~75 mL, enabling low-volume screening; its design substantially reduces media and reagent consumption (leading to up to ~60% lower cost per run) and simplifies seed-train efforts. It supports high cell densities, utilizes ready-to-use, single-use gamma-irradiated manifolds for easy setup, and integrates with the Skaia™ Vision software to estimate cell numbers without direct sampling, making it well-suited for early-stage development in areas like cell and gene therapy, vaccines, and exosome production.
Biopharmaceutical Fermentation Systems Market Leading Companies And Competitive Benchmarking
Major companies operating in the biopharmaceutical fermentation systems market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius Stedim Biotech, GE Healthcare, Lonza Group AG, GEA Group AG, Bio-Rad Laboratories Inc., Pall Corporation, Eppendorf AG, Repligen Corporation, Agilent Technologies Inc., ABEC Inc., Pierre Guérin Technologies, Applikon Biotechnology, Infors HT, Cellexus Ltd., ZETA Holding GmbH, New Brunswick Scientific, Nova Biomedical
View The Full Biopharmaceutical Fermentation Systems Market Report:
Biopharmaceutical Fermentation Systems Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the biopharmaceutical fermentation systems market in 2025. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
